Duarte, R F
Sánchez-Ortega, I
Arnan, M
Patiño, B
Ayats, J
Sureda, A
Cuenca-Estrella, M
Article History
First Online: 31 October 2016
Competing interests
: MA, RFD and ISO have received consultation and/or speaker fees from Esteve, Gilead Science, Merck Sharp & Dohme, Pfizer and/or Schering Plough during the study period. MCE has received grant support from Astellas Pharma, bioMerieux, Gilead Sciences, Merck Sharp and Dohme, Pfizer, Schering Plough, Soria Melguizo SA and Ferrer International, has been an advisor/consultant to Astellas Pharma, Gilead Sciences, Merck Sharp and Dohme, Pfizer and Schering Plough, and has received honoraria for talks on behalf of Gilead Sciences, Merck Sharp and Dohme, Pfizer, Astellas Pharma and Schering Plough. The remaining authors declare no conflict of interest.